Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
<p>Abstract</p> <p>The development of a vaccine against respiratory syncytial virus (RSV) has been hampered by the risk for vaccine-enhanced RSV pulmonary disease induced by immunization with formalin-inactivated RSV (FIRSV). This study focuses on the evaluation of vaccine-enhanced...
Main Authors: | Krause Anja, Xu Yaqin, Ross Sara, Wu Wendy, Joh Ju, Worgall Stefan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/8/1/375 |
Similar Items
-
Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
by: Lawrence Petherbridge, et al.
Published: (2023-11-01) -
RSV vaccine use - the missing data
by: Drysdale, S, et al.
Published: (2015) -
A multifaceted approach to RSV vaccination
by: Jorge C. G. Blanco, et al.
Published: (2018-07-01) -
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01) -
Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV
by: Rika Gomi, et al.
Published: (2018-12-01)